School of Medicine
Showing 1-6 of 6 Results
-
Alice C. Fan
Assistant Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
-
Dean W. Felsher
Professor of Medicine (Oncology) and of Pathology
Current Research and Scholarly InterestsMy laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.
-
George A. Fisher Jr.
Colleen Haas Chair in the School of Medicine
Current Research and Scholarly InterestsClinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials.
-
Jessica Foran, MSN, NP, RN, ANP-BC, WHNP-BC
Affiliate, Medicine - Med/Oncology
BioJessica Foran, MSN, NP, RN, ANP-BC, WHNP-BC is an advanced practice provider who specializes in breast medical oncology at the Stanford Women's Cancer Center. She graduated with her Adult Health Nurse Practitioner (ANP) and Women's Health Nurse Practitioner (WHNP) degrees from MGH Institute of Health Professions and her Bachelors of Science in Nursing (BSN) degree from Johns Hopkins University School of Nursing. Jessica Foran has special interest in breast oncology, clinical research, survivorship, and reproductive health.
-
James Ford
Professor of Medicine (Oncology) and of Genetics and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNAdamage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.